Fans of “Star Wars” and Coke can take a refreshing dive into the “Star Wars” universe with the latest can collaboration ...

Earlier this week, the pharma giant publicly accused Hims & Hers of “deceptive” marketing that is putting patient safety at risk.

NeuroScientific Biopharmaceuticals has ventured into the stem cell therapy market with a $5.1 million purchase of unlisted Perth-based company Isopogen.

Elutia is a winner in the Innovation and Product Launches categories in the 2025 Medical Device Network Excellence Awards.

Hiking in a slot canyon wearing a plaid flannel shirt is a symptom of having moderate to severe rheumatoid arthritis.

Anaphylm's FDA approval process is a major catalyst, with a PDUFA date set for January 31, 2026. Find out why Aquestive ...

Louisiana accused pharmaceutical giant CVS of using its dominant market position to abuse customer information, drive up drug ...

Drug maker Shanghai Henlius traces its history to 1992, when four ambitious young entrepreneurs formed Fosun Group to seize ...

Novo Nordisk A/S scrapped a partnership with Hims & Hers Health Inc. after less than two months, saying the US company is ...

D-Wave achieved practical quantum supremacy, solving real-world problems in minutes, vs. classical supercomputers requiring ...

Upfront cash of $25 million and milestone payments totalling up to $150 million contingent upon Recordati achieving predefined annual commercial net sales levels; Supply-based revenues, including ...

I cannot, for the life of me, grasp the thought behind infomercial products that combine using the restroom with golf, but ...